Viola Akopian, Ph.D.
Dr. Violetta Akopian joined Regulus in January 2014 as Senior Director, Quality and Drug Product Development and was promoted to Vice President, Pharmaceutical Development in September 2016. Prior to Regulus, Dr. Akopian was responsible for CMC and Quality for Nitto Denko Technical Corporation’s (now Nitto Biopharma) Molecular Therapeutics Department. Prior to Nitto Biopharma, Dr. Akopian held multiple senior positions in pharmaceutical companies and government agencies in Canada, leading manufacturing and CMC development programs for oligonucleotide-based therapeutics. Dr. Akopian obtained a M.Sc. in Biochemistry and a Ph.D. in Biology at the Russian Academy of Science in St. Petersburg. She received her post-doctoral training at Erasmus University of Rotterdam and in the Department of Cancer Endocrinology at the BC Cancer Agency.